Leveraging a Precision Medicine Platform to Predict Novel Therapies for Malignant Peripheral Nerve Sheath Tumors

syn52369030

Created By NF Service nf-osi-service

dataType:
grantDOI:
keywords:
studyName: Leveraging a Precision Medicine Platform to Predict Novel Therapies for Malignant Peripheral Nerve Sheath Tumors
dataStatus: Under Embargo
initiative: Synergistic Idea Award
studyLeads: Sara Gosline Angela Hirbe David Largaespada Christine Pratilas David Wood
studyStatus: Active
diseaseFocus: Neurofibromatosis type 1
grantEndDate: 1785456000000
institutions: Pacific Northwest National Laboratory
clinicalTrial:
fundingAgency: CDMRP
manifestation:
embargoEndDate: 1816992000000
grantStartDate: 1690848000000
relatedStudies: syn21984813 syn11638893 syn51907739 syn51117783
studyFileviewId: syn52369043
alternateDataRepository:
syn52369031
syn53503360
syn52369032
syn52369043
syn52369033
syn68492144
syn73851034
syn73851037
syn73851044
syn73851040
syn73851033
syn73851039
syn73851028
syn73851041
syn73851042
syn73851045
syn73851046
syn73851038
syn73851035
syn73851036
syn65473033
syn64693163
syn53696870

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Leveraging a Precision Medicine Platform to Predict Novel Therapies for Malignant Peripheral Nerve Sheath Tumors

syn52369030

Drop files to upload

Leveraging a Precision Medicine Platform to Predict Novel Therapies for Malignant Peripheral Nerve Sheath Tumors page is loading…